Menthol from everyday sources like peppermint tea, candy, or topical pain creams has not been shown to damage healthy kidneys in humans. No clinical trial or epidemiological study has linked normal dietary menthol intake to kidney injury. The research that does exist is almost entirely from animal models and cell-culture experiments, and it tells a more complicated story than a simple safe-or-dangerous verdict. Some of that research actually points toward kidney-protective effects, while a few lab findings raise questions about concentrated exposure, particularly through e-cigarettes.
How Your Body Processes Menthol
When you swallow menthol, whether in a peppermint oil capsule, a mint, or a cup of tea, your liver converts it quickly into a compound called menthol glucuronide. This is a standard detoxification step: the liver attaches a sugar molecule to menthol, making it water-soluble so the kidneys can filter it out. The process is fast. After taking a menthol capsule, the glucuronide form in blood has a half-life of roughly 56 minutes, meaning half of it clears every hour. With mint tea or candy, that half-life drops to about 43 minutes.
1PubMed. Disposition kinetics and effects of mentholYour kidneys do most of the heavy lifting when it comes to elimination. Roughly half of ingested menthol ends up in urine as the glucuronide metabolite.
1PubMed. Disposition kinetics and effects of menthol The fact that this metabolite, rather than raw menthol, is what appears in both plasma and urine tells you that the body is handling it efficiently. You are not bathing your kidneys in free menthol; you are bathing them in a deactivated byproduct that is on its way out.
2PubMed. Determination of menthol and menthol glucuronide in human urine by gas chromatography using an enzyme-sensitive internal standard and flame ionization detectionAnimal Studies Suggesting Kidney Protection
If anything, the animal data lean toward menthol being good for kidneys rather than bad. In rats given thioacetamide, a chemical that induces kidney scarring, menthol treatment prevented the buildup of collagen in kidney tissue and blocked the histological damage researchers would normally expect. More concretely, menthol prevented the rise in serum creatinine and blood urea nitrogen (BUN), two standard markers of kidney dysfunction.
3PubMed. Menthol ameliorates thioacetamide-induced renal fibrosis in rats by upregulating SIRT1/Nrf2 and downregulating TGF-β1/Smad3 signalling pathwaysThe mechanism appears to involve two cellular defense pathways. Menthol boosted a protein called SIRT1, which helps cells manage stress, and activated Nrf2, which ramps up antioxidant defenses. At the same time, menthol dialed down TGF-β1/Smad3 signaling, a pathway that drives scar-tissue formation in the kidney. In other words, menthol simultaneously strengthened the kidney’s natural defenses and dampened the signals telling the kidney to scar over. This is a single study in rats with chemically induced injury, so it does not prove that menthol supplements protect human kidneys. But the direction of the finding matters: researchers were specifically looking for harm and found the opposite.
3PubMed. Menthol ameliorates thioacetamide-induced renal fibrosis in rats by upregulating SIRT1/Nrf2 and downregulating TGF-β1/Smad3 signalling pathwaysA separate line of research looked at polycystic kidney disease, a genetic condition in which fluid-filled cysts gradually replace healthy kidney tissue. In mice engineered to develop this disease, activating the cold-sensing receptor TRPM8 with menthol suppressed cyst growth, reduced kidney weight relative to body weight, and lowered BUN and fibrosis markers. The proposed mechanism is that menthol-driven calcium signaling through TRPM8 restricts the overactive mitochondrial function that fuels cyst expansion and tubular cell death in this disease.
4Nephrology Dialysis Transplantation. Mitigation of tubular apoptosis and cystogenesis in ADPKD: the impact of TRPM8 through restriction of mitochondrial functionThe TRPM8 Receptor Complicates the Picture
Menthol’s most studied biological target is TRPM8, a receptor originally identified as the sensor that makes your skin feel “cool” when you eat a mint or step into cold air. This receptor is also present in blood vessels, sensory neurons, and kidney tissue, which is why researchers keep circling back to it. The polycystic kidney disease study described above suggests TRPM8 activation is protective in that context. But a different body of research reaches a more unsettling conclusion about TRPM8 and chronic kidney disease (CKD).
In kidney tissue from patients with CKD, TRPM8 gene expression tracked with the progression of interstitial fibrosis, tubular atrophy, and protein in the urine. When researchers genetically deleted TRPM8 in mice that were fed a diet designed to induce CKD, the deletion blunted the expected rises in BUN and creatinine. Removing TRPM8 also reduced inflammation and fibrosis by improving the integrity of endothelial cells that line small blood vessels, boosting autophagy (the cell’s self-cleaning process), and increasing antioxidant capacity.
5PubMed. Genetic deletion of TRPM8 channels restores microvascular function and mitigates chronic kidney disease progressionThis sets up an apparent contradiction. In polycystic kidney disease, turning TRPM8 on with menthol helped. In a diet-induced CKD model, turning TRPM8 off helped. How can both be true? The likely answer is that TRPM8 plays different roles depending on the type of kidney injury and the cellular context. Polycystic kidney disease is fundamentally a disorder of cell proliferation and cyst formation; CKD involves chronic inflammation, vascular damage, and scarring. A receptor that dampens one process may accelerate the other. This is not unusual in biology. Many receptors have context-dependent effects that can look contradictory from the outside.
For the average person wondering whether menthol tea is bad for their kidneys, the honest takeaway is that no one has demonstrated harm from dietary menthol in humans with or without CKD. But the TRPM8 findings do suggest that if pharmacological menthol-based therapies are ever developed for kidney disease, the specific type of kidney disease would matter enormously.
Menthol in E-Cigarettes and Vaping
The context where menthol and kidneys start to look more concerning is vaping. A laboratory study exposed HK-2 cells, a line of human kidney tubule cells commonly used in nephrotoxicity research, to menthol at concentrations ranging from roughly 200 to 1,500 micromolar. At these levels, menthol was cytotoxic: it impaired cell function within 24 hours, damaged mitochondria at lower concentrations than those needed to breach cell membranes, and at the highest concentration triggered markers of autophagy stress.
6ScienceDirect / The Journal of Pharmacology and Experimental Therapeutics. Renal Cytotoxicity of the E-Vaping Flavoring Agent MentholTwo caveats matter here. First, this is a cell-culture study: kidney cells sitting in a dish were dosed with menthol directly, bypassing all the metabolic processing your liver would perform if you inhaled or swallowed menthol. The concentrations used are likely far higher than what kidney tissue would encounter after someone takes a puff from a menthol vape. Second, the fact that mitochondrial impairment showed up at lower concentrations than outright cell death suggests that subtler, longer-term damage could theoretically occur at exposure levels below the overtly toxic threshold. Whether that translates into real-world kidney injury in people who vape menthol regularly has not been studied.
This is the kind of early-stage finding that justifies monitoring rather than alarm. No one has measured menthol concentrations in the kidneys of vapers, and no epidemiological study has isolated menthol flavoring from the many other chemicals in e-cigarette aerosol as a cause of kidney damage. Still, the study is worth knowing about if you vape menthol-flavored products frequently, because it points to a plausible mechanism of harm that simply has not been tested in living people yet.
Effects on Kidney Cell Barriers
Another laboratory finding worth noting involves the tight junctions between kidney cells. Tight junctions are the seals that hold cells together in an epithelial layer, controlling what passes between them. In kidney tubules, these junctions help regulate which substances get reabsorbed and which get flushed out. When researchers exposed MDCK cells (a kidney-derived cell line used to study barrier function) to menthol, the tight junction proteins were visibly reduced, and transepithelial electrical resistance, a measure of how intact the barrier is, dropped significantly.
7ScienceDirect (Elsevier) / Journal of Traditional Chinese Medical Sciences. Influence of puerarin, paeoniflorin, and menthol on structure and barrier function of tight junctions in MDCK and MDCK-MDR1 CellsThis finding actually comes from the field of drug delivery research, where menthol’s ability to loosen tight junctions is considered a useful feature for getting drugs across biological barriers. In traditional Chinese medicine formulations, menthol is sometimes included as a “penetration enhancer” precisely because it opens up these cellular seals. Whether this effect occurs at the concentrations your kidneys encounter from dietary menthol is unknown, and there is a vast difference between bathing cultured cells in menthol and drinking a cup of peppermint tea. But the finding underscores that menthol is biologically active at the kidney-cell level, not inert.
Blood Pressure, Blood Vessels, and the Kidney Connection
High blood pressure is the second leading cause of kidney disease, so anything that lowers blood pressure has indirect kidney relevance. Menthol’s effects on blood vessels have been studied in some detail, and the results are encouraging for the blood-pressure question.
In genetically hypertensive rats, chronic dietary menthol blunted constriction in the mesenteric arteries and lowered blood pressure overall. The mechanism went through the same TRPM8 receptor discussed earlier: menthol activation of TRPM8 inhibited a signaling cascade that drives vascular smooth muscle contraction, and the blood-pressure-lowering effect disappeared in mice lacking TRPM8.
8PubMed. Activation of cold-sensing transient receptor potential melastatin subtype 8 antagonizes vasoconstriction and hypertension through attenuating RhoA/Rho kinase pathwayMenthol’s vascular effects are not uniform across the body, though. A review of the evidence found that menthol increases blood flow in skin regions where it is directly applied, through a combination of increased nitric oxide and sensory nerve responses. But in deeper vascular territories not directly exposed to menthol, perfusion actually decreases, likely as part of a reflexive heat-conservation response.
9Frontiers in Physiology (via Europe PMC). Current Knowledge on the Vascular Effects of MentholThe kidneys are deep organs, which raises the question of whether systemic menthol exposure from food or supplements might transiently reduce kidney blood flow rather than increase it. No one has measured this directly, and the reflex described above has been studied mainly in the context of topical menthol on skin. But it is a reminder that “menthol relaxes blood vessels” is an oversimplification. The effect depends on which vessels you are talking about and how the menthol gets there.
Topical Menthol Products
Many people encounter menthol not through food but through pain-relief creams, muscle rubs, and patches. These products use menthol as a counterirritant: it activates and then desensitizes sensory nerve endings in the skin, producing a cooling sensation that competes with pain signals. The menthol concentration in over-the-counter topical products typically ranges from about 1% to 16%, depending on the formulation.
Systemic absorption from topical menthol products is low compared to oral ingestion. Some menthol enters the bloodstream through the skin, but the amount reaching internal organs like the kidneys is much smaller than what arrives after swallowing a peppermint oil capsule. No case reports or studies link topical menthol use to kidney injury. If you are using a menthol cream for sore muscles or a patch for back pain, the kidney-safety question is essentially a non-issue based on current evidence.
People With Existing Kidney Disease
The question shifts meaningfully if your kidneys are already compromised. In healthy kidneys, menthol gets processed into its glucuronide form and filtered out within an hour or two. But kidneys with reduced filtration capacity clear waste more slowly, which could in theory lead to higher circulating levels of menthol or its metabolites after a given dose. No study has measured menthol pharmacokinetics specifically in people with reduced kidney function.
The TRPM8 data from the CKD mouse model is the finding that deserves the most caution here. If TRPM8 activation genuinely worsens the inflammatory and fibrotic processes in chronic kidney disease, as that study suggests, then people with existing CKD might want to be conservative about concentrated menthol supplements.
5PubMed. Genetic deletion of TRPM8 channels restores microvascular function and mitigates chronic kidney disease progression That said, the leap from “deleting a receptor in mice helped” to “menthol supplements worsen CKD in people” is enormous. Normal dietary amounts from tea or candy are unlikely to deliver enough menthol to strongly activate TRPM8 in the kidneys. But high-dose peppermint oil capsules, which some people take for digestive symptoms, deliver meaningfully more menthol per dose, and no one has studied their effects in CKD patients specifically.
The practical guidance for someone with kidney disease is straightforward: peppermint tea and occasional mints are not worth worrying about. If you are taking concentrated peppermint oil capsules regularly and you have diagnosed kidney disease, mention it to your nephrologist. Not because there is evidence of harm, but because there is an absence of evidence of safety in that specific population, and the TRPM8 research gives a biological reason to be cautious.
Why the Research Is So Thin
You might wonder why there is so little human data on menthol and kidneys. The answer is partly that menthol has been classified as “generally recognized as safe” by food-safety regulators for decades, based on its long history of dietary use without obvious toxicity signals. When a compound has that status, funding agencies and pharmaceutical companies have little incentive to run expensive kidney trials. The research that does exist tends to come from adjacent fields: vaping toxicology, polycystic kidney disease genetics, traditional Chinese medicine drug-delivery research, and cardiovascular physiology. Each field stumbled into menthol’s kidney effects while studying something else.
The TRPM8 receptor has become a hot research topic in the past decade, which is pulling more attention toward menthol’s effects on various organ systems. The conflicting results between the CKD model and the polycystic kidney disease model illustrate how early this science still is. Researchers are still working out the basics of what TRPM8 does in the kidney, let alone whether menthol intake matters for human kidney outcomes. The cell-culture toxicity data from the vaping study adds another layer, because the regulatory conversation around e-cigarette flavoring chemicals is intensifying and may eventually drive more systematic nephrotoxicity testing.
For now, the gap between laboratory observations and clinical reality remains wide. Menthol can damage kidney cells in a dish at high concentrations. It can loosen tight junctions in a cultured cell layer. It can also protect kidneys from scarring in a rat model and slow cyst growth in a mouse model. None of these findings directly predicts what happens in a person drinking peppermint tea, and the distance between a petri dish and a functioning human body is where most toxicology stories quietly collapse.